Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Neutrophil degranulation and extracellular ROS production are inactivated by Yersinia pseudotuberculosis YopE through a SKAP2 independent pathway.

bioRxiv : the preprint server for biology·2026
Same author

Host Aging Induces a Senescent-Like Phenotype in Neutrophils and Altered Transcriptional Responses to Streptococcus pneumoniae.

Aging cell·2026
Same author

Host aging induces a senescent-like phenotype in neutrophils and altered transcriptional responses to <i>Streptococcus pneumoniae</i>.

bioRxiv : the preprint server for biology·2025
Same author

Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Non-canonical autophosphorylation of RIPK1 drives timely pyroptosis to control Yersinia infection.

Cell reports·2024
Same author

Blocking HXA<sub>3</sub>-mediated neutrophil elastase release during <i>S. pneumoniae</i> lung infection limits pulmonary epithelial barrier disruption and bacteremia.

mBio·2024

Video Experimental Relacionado

Updated: Jul 6, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Genética evolutiva: mutación CCR5 y protección contra la peste.

Joan Mecsas1, Greg Franklin, William A Kuziel

  • 1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305-5402, USA.

Nature
|February 13, 2004
PubMed
Resumen

La deficiencia de CCR5 puede no proteger contra la peste bubónica. Los investigadores infectaron ratones normales y con deficiencia de CCR5 con Yersinia pestis, sin encontrar diferencias en los resultados, lo que sugiere que la mutación no ofrece protección contra esta bacteria mortal.

Más Videos Relacionados

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
09:12

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments

Published on: March 28, 2025

Videos de Experimentos Relacionados

Last Updated: Jul 6, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
09:12

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments

Published on: March 28, 2025

Área de la Ciencia:

  • Inmunología Inmunología.
  • Genética La genética.
  • Enfermedades infecciosas Enfermedades infecciosas.
  • La medicina evolutiva es la medicina de la evolución.

Sus antecedentes:

  • Se ha planteado la hipótesis de que una mutación prevalente del CCR5 (receptor de quimiocinas tipo 5) en las poblaciones del norte de Europa confiere protección contra Yersinia pestis, la bacteria responsable de la peste bubónica.
  • El impacto histórico de las epidemias de peste, particularmente la de la Edad Media, pone de relieve las importantes implicaciones para la salud pública de comprender las interacciones huésped-patógeno y los posibles factores de resistencia genética.

Objetivo del estudio:

  • Investigar el papel de la deficiencia de CCR5 en la susceptibilidad y resistencia a la infección por Yersinia pestis.
  • Para probar experimentalmente el efecto protector propuesto de la mutación CCR5 contra la peste bubónica.

Principales métodos:

  • Infección de ratones genéticamente modificados que carecen de receptores CCR5 funcionales con Yersinia pestis.
  • Comparación de la cinética del crecimiento bacteriano y las tasas de supervivencia entre ratones con deficiencia de CCR5 y ratones normales (tipo salvaje).
  • Utilizando un modelo murino para simular la infección por Yersinia pestis relevante para la peste bubónica.

Principales resultados:

  • No se observaron diferencias significativas en el crecimiento bacteriano de Yersinia pestis entre ratones normales y ratones con deficiencia de CCR5.
  • Los tiempos de supervivencia después de la infección por Yersinia pestis fueron comparables en ambos grupos experimentales (ratones normales frente a ratones con deficiencia de CCR5).
  • La deficiencia de CCR5 no confería ninguna ventaja o protección discernible contra los efectos letales de la bacteria en el modelo estudiado.

Conclusiones:

  • Los hallazgos sugieren que es poco probable que la deficiencia de CCR5 sea el factor protector contra la peste bubónica en humanos.
  • El estudio indica que el vínculo propuesto entre la mutación CCR5 y la resistencia a la peste puede no ser válido, a menos que la patogénesis de Yersinia pestis difiera significativamente entre ratones y humanos.
  • Se requiere más investigación para explorar otros posibles factores genéticos o ambientales que influyen en la resistencia humana a Yersinia pestis.